![Pharmacology / Discovery and development of tubulin inhibitors / Basilea Pharmaceutica / Medicine / Angiogenesis Pharmacology / Discovery and development of tubulin inhibitors / Basilea Pharmaceutica / Medicine / Angiogenesis](https://www.pdfsearch.io/img/7225dfc3469cdf73fab47408bfe8bc3d.jpg)
| Document Date: 2014-06-23 09:59:40 Open Document File Size: 37,41 KBShare Result on Facebook
City Basel / Chicago / / Company Basilea Pharmaceutica International Ltd. / Basilea Basilea Pharmaceutica Ltd. / Basilea Pharmaceutica Ltd. / 2 Basilea Pharmaceutica Ltd. / / Country Switzerland / United States / / / Event FDA Phase / / IndustryTerm Cancer Therapeutics / pharmaceutical products / / MedicalCondition tumor / Cancer / bacterial infections / advanced solid tumors / nausea / selected solid tumor / peripheral neuropathy / well-manageable / transient hypertension / vomiting / preclinical cancer / numerous drug-refractory tumor / stable disease / pre-treatment tumor / diarrhea / drug refractory breast cancers / fungal infections / / MedicalTreatment intravenous infusion / / Organization American Association of Cancer Research / American Society of Clinical Oncology / / Person Achim Kaufhold / Nils Schröder / Barbara Zink / / / Position Chief Medical Officer / PhD Head Corporate Development Head Public Relations & Corporate Communications / / Product BAL101553 / BAL27862 / / PublishedMedium Cancer Research / / Technology pharmacokinetics / pharmacodynamics / / URL http /
SocialTag |